Effects of Berberine on 6-hydroxydopamine-induced Parkinsonism in rats

Korean Journal of Pharmacognosy

Volumn 40, Issue 4, 2009, Pages 351-356

  Kwon, Ik Hyun ^a   Choi, Hyun Sook ^a   Shin, Kun Seong ^a   Hwang, Bang Yeon ^a   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

Author keywords

6 Hydroxydopamine induced cytotoxicity; 6 Hydroxydopamine lesioned rats; Berberine; Dopamine; PC12 cells

Indexed keywords

BERBERINE; DOPAMINE; ISOQUINOLINE; LEVODOPA; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LOSS; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINE BLOOD LEVEL; DOPAMINERGIC ACTIVITY; LESIONS AND DEFECTS; NONHUMAN; PARKINSONISM; RAT; SUBSTANTIA NIGRA;

EID: 77958542997     PISSN: 02533073     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Fearnley, M. and Lees, A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 114: 2283-2301.
2. McNaught, K. S., Carrupt, P. A., Altomare, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P. and Marsden, C. D. (1998) Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56: 921-933.
3. Jung, Y. J. and Surh, Y. J. (2001) Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Rad. Biol. Med. 30: 1407-1417.
4. Shin, J. S., Kim, E. I., Kai, M. and Lee, M. K. (2000) Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25: 363-368.
5. Shin, J. S., Kim, K. T. and Lee, M. K. (1998) Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett. 244: 161-164.
6. Shin, J. S., Lee, J. J., Kim, Y., Lee, C. K., Yun, Y. P. and Lee, M. K. (2001) Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull. 24: 103-105.
7. Shin, J. S., Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1999) Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65: 452-455.
8. Yin, S. Y., Kim Y. M., Lee, J. J., Jin, C. M., Yang, Y. J., Ma, J. J., Kang, M. H., Kai, M. and Lee, M. K. (2004) Enantio-selective inhibition of (1R,9S)- and (1S,9R)-ß-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol. 47: 1045-1052.
9. Kim, Y, M., Kim, M, N., Lee, J. J. and Lee, M. K. (2005) Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 386: 1-4.
10. Kim, S. H., Shin, J. S., Lee, J. J., Yin, S. Y., Kai, M. and Lee, M. K. (2001) Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67: 609-613.
11. Zhang, Y. H., Shin, J. S., Lee, S. S., Kim, S. H. and Lee, M. K. (1997) Inhibition of tyrosine hydroxylase by bulbocapnine. Planta Med. 63: 362-363.
12. Jin, C. M., Lee, J. J., Yang, Y. J., Kim, Y. K., Ryu, S. Y. and Lee, M. K. (2007) Liriodenine inhibits dopamine biosynthesis and L-DOPA-induced dopamine content in PC12 cells. Arch. Pharm. Res. 30: 984-990.
13. Lee, M. K. and Zhang, Y. H. (1996) Inhibition of tyrosine hydroxylase by berberine. Med. Sci. Res. 24: 561-564.
14. Lee, S. S., Kai, M. and Lee, M. K. (1996) Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: Inhibition by berberine and palmatine. Med. Sci. Res. 27: 749-751.
15. Lee, S, S., Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1996) Inhibition of monoamine oxidase by higenamine. Med. Sci. Res. 26: 71-72.
16. Naoi, M., Matsuura, S., Parvez, H., Takahashi, T., Hirata, Y., Minami, M. and Nagatsu, T. (1989) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase. J. Neurochem. 52: 653-655.
17. Lee, J. J., Kim, Y. M., Yin, W. Y., Park, H. D., Kang, M. H., Hong, J. T. and Lee, M. K. (2003) Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66: 1787-1795.
18. Maruyama, W., Nakahara, D., Ota, M., Takahashi, T., Takahashi, A., Nagatsu, T. and Naoi, M. (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: In vivo microdialysis study. J Neurochem. 59: 395-400.
19. Naoi, M., Matsuura, S., Takahashi, T. and Nagatsu, T. (1989) A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. Biochem. Biophys. Res. Comm. 161: 1213-1219.
20. Franzblau, S. G. and Cross, C. (1986) Comparative in vitro antimicrobial activity of chinese medicinal herbs. J. Ethnopharmacol. 15: 279-288.
21. Yamahara, J. (1976) Behavioral pharmacology of berberine-type alkaloids (1), Central depressive action of Coptis Rhizoma and its constituents. Nippon Yakurigaku Zasshi. 72: 899-908.
22. Chen, H. C. and Hsieh, M. T. (1986) Two-year experience with "San-Huang-Hsih-Tang" in essential hypertension. Am. J. Chin. Med. 14: 51-58.
23. Takase, H., Imanishi, K., Miura, O. and Yumioka, E. (1989) A possible mechanism for the gastric mucosal protection by Oren-Gedoku-To (OGT), A traditional herbal medicine. Jpn. J. Pharmacol. 51: 17-23.
24. Bereese, G. and Traylor. T. (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 175: 413-420.
25. Blum, D., Wu, Y., Nissou, M.-F., Arnaud, S., Benabid, A.-L. and Verna, J.-M. (1997) p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cell. Brain Res. 751: 139-142. (Pubitemid 27122145)
26. Greene, L.,A. and Tischler, A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73: 2424-2428.
27. Paxinos, G. and Watson, C. (1986) The rat brain in stereotaxic coordinates. Australia: Academic Press.
28. Mitsui, A., Nohta, H. and Ohkura, Y. (1985) High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent. J. Chromatogr. 344: 61-70.
29. Lowry, O. H., Rosenbrough, N. L., Farr, A. L. and Randall, R. L. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
30. Saito, Y., Nishio, K., Ogawa, Y., Kinumi, T., Yoshida, Y., Masuo, Y. and Niki, E. (2007) Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and -independent action. Free Rad. Biol. Med. 42: 675-685.
31. Perese, D, A., Ulman, J., Viola, J., Ewing, S. E. and Bankiewicz, K. S. (1989) A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res. 494: 285-293. (Pubitemid 19194542)
32. Jenner, P. and Olanow, C. W. (1996) Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders. In: C.W. Olanow, P. Jenner and M. Youdim. (ed.) Neurodegeneration and Neuroprotection in Parkinson's Disease. 23-45, Academic Press, London.
33. Fahn, S. and Cohen, G. (1992) The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32: 804-812.
34. Migheli, R., Godani, C., Sciola, L., Delogu, M. R., Serra, P. A., Zangani, D., De Natale, G., Miele, E. and Desole, M. S. (1999) Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: Role of oxidative stress. J. Neurochem. 73: 1155-1163. (Pubitemid 29395474)